182 related articles for article (PubMed ID: 38274799)
1. Gut microbiota analyses of cutaneous T-cell lymphoma patients undergoing narrowband ultraviolet B therapy reveal alterations associated with disease treatment.
Nguyen WQ; Chrisman LP; Enriquez GL; Hooper MJ; Griffin TL; Ahmad M; Rahman S; Green SJ; Seed PC; Guitart J; Burns MB; Zhou XA
Front Immunol; 2023; 14():1280205. PubMed ID: 38274799
[TBL] [Abstract][Full Text] [Related]
2. Narrowband ultraviolet B response in cutaneous T-cell lymphoma is characterized by increased bacterial diversity and reduced
Hooper MJ; Enriquez GL; Veon FL; LeWitt TM; Sweeney D; Green SJ; Seed PC; Choi J; Guitart J; Burns MB; Zhou XA
Front Immunol; 2022; 13():1022093. PubMed ID: 36439132
[TBL] [Abstract][Full Text] [Related]
3. Gut dysbiosis in cutaneous T-cell lymphoma is characterized by shifts in relative abundances of specific bacterial taxa and decreased diversity in more advanced disease.
Hooper MJ; LeWitt TM; Pang Y; Veon FL; Chlipala GE; Feferman L; Green SJ; Sweeney D; Bagnowski KT; Burns MB; Seed PC; Choi J; Guitart J; Zhou XA
J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1552-1563. PubMed ID: 35366365
[TBL] [Abstract][Full Text] [Related]
4. Alteration of gut microbiota during narrowband ultraviolet B therapy in psoriasis: A preliminary study.
Rungjang A; Meephansan J; Payungporn S; Sawaswong V; Chanchaem P; Pureesrisak P; Wongpiyabovorn J; Thio HB
Exp Dermatol; 2022 Aug; 31(8):1281-1288. PubMed ID: 35737868
[TBL] [Abstract][Full Text] [Related]
5. Nasal Dysbiosis in Cutaneous T-Cell Lymphoma Is Characterized by Shifts in Relative Abundances of Non-
Hooper MJ; LeWitt TM; Veon FL; Pang Y; Chlipala GE; Feferman L; Green SJ; Sweeney D; Bagnowski KT; Burns MB; Seed PC; Guitart J; Zhou XA
JID Innov; 2022 Sep; 2(5):100132. PubMed ID: 36161104
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the skin microbiome in cutaneous T-cell lymphoma delays tumour growth and increases survival in the murine EL4 model.
Dey S; Vieyra-Garcia PA; Joshi AA; Trajanoski S; Wolf P
Front Immunol; 2024; 15():1255859. PubMed ID: 38646524
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of bexarotene combined with photo(chemo)therapy for cutaneous T-cell lymphoma.
Morita A; Tateishi C; Muramatsu S; Kubo R; Yonezawa E; Kato H; Nishida E; Tsuruta D
J Dermatol; 2020 May; 47(5):443-451. PubMed ID: 32189402
[TBL] [Abstract][Full Text] [Related]
9. Deciphering Gut Microbiota Dysbiosis and Corresponding Genetic and Metabolic Dysregulation in Psoriasis Patients Using Metagenomics Sequencing.
Xiao S; Zhang G; Jiang C; Liu X; Wang X; Li Y; Cheng M; Lv H; Xian F; Guo X; Tan Y
Front Cell Infect Microbiol; 2021; 11():605825. PubMed ID: 33869074
[TBL] [Abstract][Full Text] [Related]
10. Combined culture and metagenomic analyses reveal significant shifts in the composition of the cutaneous microbiome in psoriasis.
Langan EA; Künstner A; Miodovnik M; Zillikens D; Thaçi D; Baines JF; Ibrahim SM; Solbach W; Knobloch JK
Br J Dermatol; 2019 Dec; 181(6):1254-1264. PubMed ID: 30985920
[TBL] [Abstract][Full Text] [Related]
11. Dysbiosis of skin microbiome and gut microbiome in melanoma progression.
Mekadim C; Skalnikova HK; Cizkova J; Cizkova V; Palanova A; Horak V; Mrazek J
BMC Microbiol; 2022 Feb; 22(1):63. PubMed ID: 35216552
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?
Forbes JD; Chen CY; Knox NC; Marrie RA; El-Gabalawy H; de Kievit T; Alfa M; Bernstein CN; Van Domselaar G
Microbiome; 2018 Dec; 6(1):221. PubMed ID: 30545401
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiome and Serum Metabolome Alterations Associated with Isolated Dystonia.
Ma L; Keng J; Cheng M; Pan H; Feng B; Hu Y; Feng T; Yang F
mSphere; 2021 Aug; 6(4):e0028321. PubMed ID: 34346706
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional Heterogeneity and the Microbiome of Cutaneous T-Cell Lymphoma.
Licht P; Mailänder V
Cells; 2022 Jan; 11(3):. PubMed ID: 35159138
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota dysbiosis in a cohort of patients with psoriasis.
Hidalgo-Cantabrana C; Gómez J; Delgado S; Requena-López S; Queiro-Silva R; Margolles A; Coto E; Sánchez B; Coto-Segura P
Br J Dermatol; 2019 Dec; 181(6):1287-1295. PubMed ID: 30920647
[TBL] [Abstract][Full Text] [Related]
16. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of Gut Microbiota in Patients with GH-Secreting Pituitary Adenoma.
Lin B; Wang M; Gao R; Ye Z; Yu Y; He W; Qiao N; Ma Z; Ji C; Shi C; Zhou X; Wang Y; Zeng F; Zhang L; Gong W; Cao Z; Zhou P; Melnikov V; Ye H; Li Y; Zhang Z; He M; Qin H; Zhang Y
Microbiol Spectr; 2022 Feb; 10(1):e0042521. PubMed ID: 35019688
[TBL] [Abstract][Full Text] [Related]
18. Case series of cutaneous T-cell lymphomas treated with bexarotene-based therapy.
Fujimura T; Sato Y; Tanita K; Amagai R; Shimauchi T; Ogata D; Fukushima S; Miyashita A; Fujisawa Y; Kambayashi Y; Aiba S
J Dermatol; 2020 Jun; 47(6):636-640. PubMed ID: 32207181
[TBL] [Abstract][Full Text] [Related]
19. Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis.
Miyagaki T; Sugaya M; Suga H; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e60-7. PubMed ID: 22404649
[TBL] [Abstract][Full Text] [Related]
20. Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis.
Nevala H; Karenko L; Vakeva L; Ranki A
Br J Dermatol; 2001 Dec; 145(6):928-37. PubMed ID: 11899146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
